TO STUDY THE EFFECT OF PANCHKOLASAV IN PUERPURAL UTERINE INVOLUTION AFTER FULL TERM NORMAL DELIVERY.

A RANDOMIZED OPEN CONTROLLED TRIAL OF PANCHKOLASAV IN PUERPURAL UTERINE INVOLUTION AFTER FULL TERM NORMAL DELIVERY.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/10/037655

Enrollment

Registered

2021-10-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O908- Other complications of the puerperium, not elsewhere classified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)full term vaginal normal delivery. 2)Patient age group 20 to 35. 3)Irrespective of religion ,cast, parity, socioeconomic condition will be include

Exclusion criteria

Exclusion criteria: 1)Preterm labour, LSCS. 2) Puerperal hypertension and gestational hypertension. 3)Pre-eclampsia and gross anaemia. 4)Immuno suprresive disease. 5)Any underlined medical illness and obstetrics illnesses.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Panchkolasav in Puerperal Uterine Involution After Full Term Normal Delievery .Timepoint: 45 days	—

Secondary

Measure	Time frame
To compare the efficacy of Panchkolasav and Tablet- Calcium,Tab-Iron 60mg and Antibiotic if requiredTimepoint: 18 months	—

Countries

India

Contacts

Public ContactVdTinkuGanesh Khalache

Hon.Shri.Annasaheb Dange Ayurvedic Medical College and Post graduate Research Centre,Ashta

tinkuganeshkhalache@gmail.com9423041730

Outcome results